Takagi clinic

Sendai, Miyagi 981-3213

1 studies enrolling now · 3 studies all time

What they study most

Crohn's Disease, Moderately to Severely Active Crohns Disease, Ulcerative Colitis

Studies at this site

• A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis — Stopped early
• A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease — Completed